{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:36:46Z","timestamp":1785465406675,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ygyno.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T12:45:04Z","timestamp":1624452304000},"page":"575-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol"],"prefix":"10.1016","volume":"162","author":[{"given":"Severien","family":"Van Keer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy","family":"Vanden Broeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Doyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebren A.A.","family":"Tjalma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Weyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Vorsters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.06.010_bb0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"Zur Hausen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.cmi.2020.03.033","article-title":"Commercially available molecular tests for human papillomaviruses: a global overview","volume":"26","author":"Poljak","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2021.06.010_bb0020","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0035","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0045","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/1471-0528.14682","article-title":"HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population","volume":"124","author":"Leeman","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0050","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/jwh.2019.8132","article-title":"Racial and ethnic differences in acceptability of urine and cervico-vaginal sample self-collection for HPV-based cervical cancer screening","volume":"29","author":"Rohner","year":"2020","journal-title":"J. Women\u2019s Health"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0055","first-page":"513","article-title":"Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions","volume":"163","author":"Sellors","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2015.11.005","article-title":"Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer","volume":"74","author":"Senkomago","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025388","article-title":"Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening","volume":"9","author":"Sargent","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0070","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1186\/s12879-020-05663-7","article-title":"Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays","volume":"20","author":"Tranberg","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0075","doi-asserted-by":"crossref","first-page":"g5264","DOI":"10.1136\/bmj.g5264","article-title":"Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis","volume":"349","author":"Pathak","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0080","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1158\/1940-6207.CAPR-16-0038","article-title":"Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia","volume":"9","author":"Combita","year":"2016","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0085","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10096-017-3179-1","article-title":"Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples","volume":"37","author":"Van Keer","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0090","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s10096-014-2147-2","article-title":"Optimization of HPV DNA detection in urine by improving collection, storage, and extraction","volume":"33","author":"Vorsters","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10096-011-1358-z","article-title":"Detection of human papillomavirus DNA in urine. A review of the literature","volume":"31","author":"Vorsters","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0100","first-page":"5413","article-title":"Detection and genotyping of human papillomavirus virus (HPV): a comparative analysis of clinical performance in cervical and urine samples in Chilean women","volume":"11","author":"Buchegger","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01443-19","article-title":"Test accuracy of human papillomavirus in urine for detection of cervical intraepithelial neoplasia","volume":"58","author":"Rohner","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.06.010_bb0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1158\/1055-9965.EPI-20-1226","article-title":"A randomised comparison of different vaginal self-sampling devices and urine for human papillomavirus testing - predictors 5.1","volume":"30","author":"Cadman","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010660","article-title":"Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the Papillomavirus Dumfries and Galloway-PaVDaG study)","volume":"6","author":"Stanczuk","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jmv.25597","article-title":"Comparison of the performance of paired urine and cervical samples for cervical cancer screening in screening population","volume":"92","author":"Xu","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0125","article-title":"Randomized controlled trial evaluating the utility of urine HPV DNA for cervical cancer screening in a Pacific Island population","volume":"2","author":"Hernandez","year":"2018","journal-title":"J. Glob. Health Rep."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcv.2018.08.006","article-title":"VALHUDES: a protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples","volume":"107","author":"Arbyn","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0135","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.06.010_bb0140","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1386-6532(09)70003-4","article-title":"Principles and analytical performance of Abbott RealTime High Risk HPV test","volume":"45","author":"Huang","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0145","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0150","unstructured":"BE 71030031000; Biobank Antwerpen@UZA B-E, Belgian No. Access: (2), Last: (specify date of last access in the format: Month, DD, YYYY). [BIORESOURCE]."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2303.2007.00464.x","article-title":"European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology","volume":"18","author":"Arbyn","year":"2007","journal-title":"Cytopathology"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0160","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(20)30122-5","article-title":"Tackling cervical cancer in Europe amidst the COVID-19 pandemic","volume":"5","author":"Arbyn","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0170","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/ijgc-2020-001617","article-title":"European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic","volume":"30","author":"Ciavattini","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0175","first-page":"248","article-title":"Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a Pap smear in France","volume":"81","author":"Lefeuvre","year":"2020","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0180","first-page":"377","article-title":"Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics","volume":"71","author":"Ducancelle","year":"2015","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.ygyno.2021.06.010_bb0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jviromet.2017.01.020","article-title":"Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples","volume":"243","author":"Lim","year":"2017","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041512","article-title":"Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study","volume":"11","author":"\u00d8rnskov","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0195","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.31391","article-title":"A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program","volume":"143","author":"Kellen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0200","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.06.010_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.04.031","article-title":"List of human papillomavirus assays suitable for primary cervical cancer screening","author":"Arbyn","year":"2021","journal-title":"Clin. Microbiol. Infect 2020."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582100490X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582100490X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:40Z","timestamp":1758772600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582100490X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S009082582100490X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}